Health, social, and economic characteristics of patients enrolled in a COVID-19 recovery program.
Health, social, and economic characteristics of patients enrolled in a COVID-19 recovery program.
复制标题
DOI:
10.1371/journal.pone.0278154
复制
发表时间:
2022
期刊:
影响因子:
3.7
通讯作者:
中科院分区:
文献类型:
--
作者:
At least one in five people who recovered from acute COVID-19 have persistent clinical symptoms, however little is known about the impact on quality-of-life (QOL), socio-economic characteristics, fatigue, work and productivity. We present a cross-sectional descriptive characterization of the clinical symptoms, QOL, socioeconomic characteristics, fatigue, work and productivity of a cohort of patients enrolled in the MedStar COVID Recovery Program (MSCRP). Our participants include people with mental and physical symptoms following recovery from acute COVID-19 and enrolled in MSCRP, which is designed to provide comprehensive multidisciplinary care and aid in recovery. Participants completed medical questionnaires and the PROMIS-29, Fatigue Severity Scale, Work and Productivity Impairment Questionnaire, and Social Determinants of Health surveys. Participants (n = 267, mean age 47.6 years, 23.2% hospitalized for COVID-19) showed impaired QOL across all domains assessed with greatest impairment in physical functioning (mean 39.1 ± 7.4) and fatigue (mean 60.6 ±. 9.7). Housing or “the basics” were not afforded by 19% and food insecurity was reported in 14% of the cohort. Participants reported elevated fatigue (mean 4.7 ± 1.1) and impairment with activity, work productivity, and on the job effectiveness was reported in 63%, 61%, and 56% of participants, respectively. Patients with persistent mental and physical symptoms following initial illness report impairment in QOL, socioeconomic hardships, increased fatigue and decreased work and productivity. Our cohort highlights that even those who are not hospitalized and recover from less severe COVID-19 can have long-term impairment, therefore designing, implementing, and scaling programs to focus on mitigating impairment and restoring function are greatly needed.
登录
查看更多内容
DOI:
10.1016/s2213-2600(21)00383-0
发表时间:
2021-11
期刊:
The Lancet. Respiratory medicine
影响因子:
--
作者:
Evans RA;McAuley H;Harrison EM;Shikotra A;Singapuri A;Sereno M;Elneima O;Docherty AB;Lone NI;Leavy OC;Daines L;Baillie JK;Brown JS;Chalder T;De Soyza A;Diar Bakerly N;Easom N;Geddes JR;Greening NJ;Hart N;Heaney LG;Heller S;Howard L;Hurst JR;Jacob J;Jenkins RG;Jolley C;Kerr S;Kon OM;Lewis K;Lord JM;McCann GP;Neubauer S;Openshaw PJM;Parekh D;Pfeffer P;Rahman NM;Raman B;Richardson M;Rowland M;Semple MG;Shah AM;Singh SJ;Sheikh A;Thomas D;Toshner M;Chalmers JD;Ho LP;Horsley A;Marks M;Poinasamy K;Wain LV;Brightling CE;PHOSP-COVID Collaborative Group
通讯作者:
PHOSP-COVID Collaborative Group
影响因子:
4.4
作者:
REILLY, MC;ZBROZEK, AS;DUKES, EM
通讯作者:
DUKES, EM
影响因子:
4.4
作者:
O'Sullivan, Oliver
通讯作者:
O'Sullivan, Oliver
DOI:
10.1016/s0004-9514(05)70002-7
发表时间:
2005
期刊:
The Australian journal of physiotherapy
影响因子:
--
作者:
Lau HM;Ng GY;Jones AY;Lee EW;Siu EH;Hui DS
通讯作者:
Hui DS
DOI:
10.1016/j.ijid.2021.07.016
发表时间:
2021-08
期刊:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
影响因子:
--
作者:
Darcis G;Bouquegneau A;Maes N;Thys M;Henket M;Labye F;Rousseau AF;Canivet P;Desir C;Calmes D;Schils R;De Worm S;Léonard P;Meunier P;Moutschen M;Louis R;Guiot J
通讯作者:
Guiot J